Dissertations / Theses on the topic 'Papillomaviruses Diagnosis'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 31 dissertations / theses for your research on the topic 'Papillomaviruses Diagnosis.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Kwan, Tak-ching Tracy, and 關德貞. "Human papillomavirus testing in cervical cancer screening: potential harms and implications for intervention." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B4658836X.
Full textSze, S. M. Candy, and 施少妹. "Evaluation and comparison of molecular diagnostic methods for detection of human papillomavirus (HPV) in relation to cervicalneoplasia." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B4501145X.
Full textSze, S. M. Candy. "Evaluation and comparison of molecular diagnostic methods for detection of human papillomavirus (HPV) in relation to cervical neoplasia /." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B37552752.
Full textCarcopino, Xavier. "Signification de la charge virale des papillomavirus humains oncogènes de type 16 et 18." Thesis, Aix-Marseille 2, 2011. http://www.theses.fr/2011AIX20704/document.
Full textUsing duplex PCR technique for the detection and quantification of HPV16 and 18, this work investigates the significance, value and limitations of the use of HPV16 and 18 viral load quantitation in routine clinical practice. Although HPV18 viral load was not found to be of any clinical relevance, HPV16 viral load was found to significantly increase with the severity of cervical lesions. However, the wide range of viral load observed strongly limitates its use in routine clinical practice. After an abnormal cervical cytology, a HPV16 viral load cut-off of 3.0x106 copies per million cells allows for the best prediction of CIN2+ (91% specificity and 58.2% sensitivity). Such cut-off is particularly efficient in case of low grade abnormal cytology (96.4% specificity and 88% sensitivity). Although HPV16 viral load does not appear to predict for HPV16 clearance in women under 30 with normal cytology, such prediction was observed among women with normal colposcopy following equivocal or low grade cytology (86.7% specificity and 85.7% sensitivity)
Correr, Wagner Rafael. "Development of impedimetric DNA sensor for diagnosis of Human Papillomavirus type 18 infection." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/76/76132/tde-05032015-144417/.
Full textA estratégia mais empregada atualmente na detecção de sequência de DNA é a PCR (Reação em Cadeira da Polimerase). Contudo, nos últimos anos, a pesquisa em biossensores de DNA tem aumentado significativamente. Estes sensores representam uma alternativa a PCR na detecção de sequências específicas de DNA, uma vez que exibem resposta rápida, baixos limites de detecção e requerem preparação simples da amostra. Nesta dissertação descrito o desenvolvimento de um biossensor para a detecção do DNA do Papilomavirus Humano tipo 18. A fim de imobilizar a sequência de captura de DNA em eletrodos de óxido de estanho e índio (ITO), realizou-se uma silanização usando 3-Aminopropiltrietoxisilano (APTES). A reação de silanização foi estudada e otimizada através das técnicas de Espectroscopia de Absorção Ultravioleta, Microscopia de Força Atômica, Microscopia de Fluorescência e Voltametria Cíclica. Após a imobilização, a hibridização com a sequência alvo é detectada através de alterações nas propriedades de superfície do eletrodo através de Voltametria Cíclica e Espectroscopia de Impedância Eletroquímica, usando o par redox Ferri-ferrocianeto. A detecção da sequência alvo sintética foi realizada no intervalo de 12.5 a 100 nM, e para o produto de PCR, 300 nM. O sensor não demonstrou resposta significativa para sequência não complementar a 50 nM. Este sensor pode ser aplicado na detecção rápida e de baixo custo de material genético do HPV a níveis nanomolares.
Trollé, Sylvine. "Infections à papillomavirus humains : application d'une méthode de détection génomique par la réaction de polymérisation en chaîne." Paris 5, 1995. http://www.theses.fr/1995PA05P115.
Full textBouchot, Olivier. "Cancer du pénis : diagnostic et indications thérapeutiques à partir d'une série de 49 cas." Nantes, 1985. http://www.theses.fr/1985NANT3462.
Full textBarbieri, Daniela <1985>. "Human papillomavirus (HPV) and associated diseases: between applied diagnostic and basic research." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5314/.
Full textIl Papillomavirus umano (HPV) è causa dei carcinomi della cervice uterina (tra cui adenocarcinomi, AdCa) ed è associato ad un sottogruppo di tumori dell’orofaringe (OPSCCs). Nonostante il rischio di sviluppo di tumore sia associato all’infezione da parte di alcuni genotipi virali, principalmente HPV16 e 18, il DNA virale da solo sembra non essere sufficiente in campo diagnosico. Inoltre, per tumori orofaringei il ruolo del virus non è ancora del tutto chiaro. Nella prima parte della tesi, sono state confrontate le performance riguardo la genotipizzazione di HPV su campioni clinici cervicali di una tecnica innovativa, basata su amplificazione e pirosequenziamento, e una di routine, basata su amplificazione e ibridazione inversa. Lo studio ha evidenziato performance simili tra le due metodiche, sottolineando per il sequenziamento una maggiore specificità e capacità di rilevare varianti intratipo. Nella seconda parte sono stati analizzati marker virologici (genotipizzazione, espressione delle oncoproteine virali, carica virale, stato fisico e metilazione del genoma di HPV16) in funzione dei dati clinici disponibili, per un possibile impiego nella diagnosi/prognosi di AdCa cervicali e OPSCCs HPV-associati. HPV16 si è confermato il genotipo prevalente in entrambe le popolazioni. La frequenza di metilazione nel promotore precoce virale ha mostrato una tendenza ad essere associata ad invasione negli AdCa, e ad una prognosi peggiore negli OPSCCs, emergendo come il più promettente marker diagnostico/prognostico. La terza parte, svolta presso il DKFZ di Heidelberg (Germania), ha visto l’analisi della risposta alla transfezione di IFN-k in linee cellulari tumorali HPV16-positive della cervice uterina e della regione testa-collo, per valutarne l’impiego terapeutico. Dopo 24h, è stato osservato un incremento dell’espressione di IFN-b e, di conseguenza, una up-regolazione dei geni coinvolti nella presentazione antigenica (MHC classe I ed immunoproteasoma) e nella risposta antivirale, specialmente nelle cellule cervicali, suggerendo la presenza di diversi meccanismi patogenetici tra tumori HPV-positivi dei due distretti anatomici.
RIHET, STEPHANE. "Diagnostic et pronostic des lesions de bas grade du col uterin liees aux papillomavirus humains." Amiens, 1997. http://www.theses.fr/1997AMIE0102.
Full textMonlun, Eric. "Diagnostic virologique des infections a papillomavirus de type 16 et 18 : mise au point d'une technique d'amplification genomique (pcr : [polymerase chain reaction])." Université Louis Pasteur (Strasbourg) (1971-2008), 1990. http://www.theses.fr/1990STR1M093.
Full textLANG, JEAN-PIERRE. "Apport des techniques d'hybridation moleculaire au diagnostic biologique : cas particulier du typage de l'h.p.v. par utilisation de sondes froides dans les lesions condylomateuses du col de l'uterus." Strasbourg 1, 1989. http://www.theses.fr/1989STR15056.
Full textLe, Cann Pierre. "Infections à papillomavirus humains de type 16 : production de capsides virales par recombinaison génétique et diagnostic sérologique à l'aide de ces antigènes et de peptides de synthèse." Tours, 1994. http://www.theses.fr/1994TOUR3804.
Full textAkhras, Michael S. "Nucleic Acid Based Pathogen Diagnostics." Doctoral thesis, KTH, Skolan för bioteknologi (BIO), 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-4684.
Full textPatogena organismer smittas till värd organismen genom alla möjliga kontaktnätverk och skapar en mångfald olika sjukdomstillstånd. Dock är det fortfarande vanligt förekommande behandlingsbara infektiösa sjukdomar som orsakar den största hälsoförlusten, sett från ett globalt perspektiv. Bill och Melinda Gates Stiftelsen samarbetade med RAND kooperation för att forma “The Global Health Diagnostics Forum”. Deras mål var att etablera och analysera matematiska modeller för vilka effekter en ny diagnostisk metod utrustat för fältarbete skulle ha i utvecklingsländer. Resultaten var häpnadsveckande, med potentiellt miljoner av liv som skulle kunna räddas på en årlig basis. Den etablerade standarden för diagnostik av patogena bakterier har länge varit kultiveringsmedia baserad. Miljö specialiserade biologer har estimerat att mindre än 1 % av alla bakterie arter går att kultivera. Dock erbjuder genetiska analyser potentialen att kunna identifiera alla mikrober från alla de biologiska rikena. Nukleinsyrebaserade diagnostiska metoder har märkbart förbättrats över de senaste årtionden. Nya tekniker erbjuder utökad sensitivitet, selektivitet, sänkta kostnader och parallella analyser av patient prover. Dock är de flesta metoderna begränsade till standardiserade laboratoriemiljöer. För att konstruera en väl fungerande diagnostisk fältutrustning för användning i problem områden, behöver världsledande tekniker identifieras och kombineras. Fokuseringsområdet för denna doktorsavhandling har varit att utveckla och utföra nukleinsyrebaserade metoder för patogen diagnostik. Metoder och experimentella utförande applicerades på två distinkta system i) sökning av antibiotika resistens relaterade mutationer i den patogena bakterien Neisseria gonorrhoeae och ii) genotypning av det cancer orsakande Humana Papillomaviruset (HPV). Den första delen av studien inriktade sig mot utveckling av snabba, direkta och multiplexa Pyrosekvenserings baserade nukleinsyreanalyser. Med förbättrad provprepareringsmetodologi kunde vi detektera multipla HPV infektioner med högre sensitivitet än vad tidigare beskrivits med liknande metodologi. Den andra delen av studien fokuserades på multiplexa nukleinsyre amplifikationer med “Molecular Inversion Probe” tekniken med sista steg Pyrosekvenserings analys. “PathogenMip assay” erbjuder ett komplett detektionsprotokoll för alla kända patogena organismer. Vi introducerar även den nya “Connector Inversion Probe”, en “Padlock Probe” kapabel att genomföra kompletta gap fyllningar för multiplex nukleinsyre amplifiering.
QC 20100624
Mathevet, Patrice. "Papillomavirus humains et lésions précancéreuses du col utérin : implication de p53, Rb, cycline D1, PCNA, R-EGF, ras." Lyon 1, 2002. http://www.theses.fr/2002LYO1T036.
Full textBatista, José Eduardo. "Prevalência de tipos específicos de HPV e anormalidades citológicas em mulheres quilombolas." Universidade Federal de Goiás, 2014. http://repositorio.bc.ufg.br/tede/handle/tede/5955.
Full textApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-08-18T12:33:39Z (GMT) No. of bitstreams: 2 Tese - José Eduardo Batista - 2014.pdf: 4845418 bytes, checksum: 4e199986cf3802d6ecf319c604412503 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2016-08-18T12:33:39Z (GMT). No. of bitstreams: 2 Tese - José Eduardo Batista - 2014.pdf: 4845418 bytes, checksum: 4e199986cf3802d6ecf319c604412503 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2014-10-23
Introduction: Genital infection by human papillomavirus (HPV) is considered the most common sexually transmitted infection in several countries. The prevalence of HPV genotypes in women with or without cytological abnormalities may vary according to the studied population and the region. Objective: To detect and identify specific HPV types correlating with sociodemographic/behavioral characteristics and cytological abnormalities present in cervical smears of Maroon women. Methods: This cross-sectional study included 353 maroon women users of the unified health System of the municipalities of Maranhão for screening of cervical cancer. The samples were analyzed for the presence of cytological abnormalities by conventional methods and tested for 37 HPV genotypes by polymerase chain reaction (PCR) with primers PGMY09/11 followed by reverse line blot hybridization performed with the Linear Array HPV Genotyping Test kit by Roche Molecular System®. The association of HPV types and cytological diagnosis was investigated according to the different age groups. Results: HPV infection was detected in 13% (46/353) of the cases. Infection types with high-risk HPV were more frequent (78,3 %, 36/46) than for low-risk HPV (21,7 %, 10/46). Genotypes 68 (24,2 % - 11 /46), 58 (19,8% - 9/46), 52 and 31 (10,8% - 5/46 each), and 62 (8,8% 4/46) were the most prevalent. Only 6,6% (3/46) of the cases were positive for HPV 61. The genotypes 73, 70, 54, 53, 45, IS39 and 18, individually represented 4,4% (2/46) of all cases. The CP6 -108, 84, 72, 71, 66, 59, 56, 55, 51, 39, 33 and 16 genotypes individually represented 2,2% (1/46) of the cases. In women without cytological abnormalities, viral infections, both simple and multiple, were detected in 10,7%(35/328) of the cases. For those diagnosed with an abnormality, the prevalence of HPV infection was 24,0% (1 /46), being higher in high grade squamous intraepithelial lesion (HSIL-75,0 %), followed by atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions (ASC-H, 50%), low grade squamous intraepithelial lesions (LSIL-33,4 %) and atypical squamous cells of undetermined significance (ASC-US, 14,3%). The analysis showed a statistically significant association between HPV infection and the detection of cytologic abnormalities in the age groups between 31-40 years (OR = 7.40, 95 % CI :1.07 -51 ,19 , p = 0.03) and 51 to 60 years (OR = 20.4 , 95 % CI : 1.12 to 704.69, p = 0.03). None of the behavioral variables showed significant association with HPV infection, however the presence of this infection was positively associated with detection of cytologic abnormalities (OR=6,57: IC:2,772-15,606), p=0,001. Conclusion: It is possible that the results of this study are due to characteristics of the study population, geographically isolated, with conservative habits and sexual intercourse only between members of the Quilombo. This study with Maroon women allowed us to delineate the epidemiology of this HPV infection in populations living in Maranhão.
Introdução: A infecção do trato genital pelo Papilomavírus humano (HPV) é considerada a infecção sexualmente transmissível (IST) mais comum em diversos países. A prevalência dos genótipos do HPV em mulheres com ou sem anormalidades citológicas pode variar de acordo com a população e a região estudada. Objetivos: Detectar e identificar os tipos específicos de HPV e relacionar com características sociodemográficas/comportamentais e anormalidades citológicas presentes em esfregaços cervicais de mulheres quilombolas do Maranhão. Metodologia: Este estudo de corte transversal incluiu 353 mulheres quilombolas usuárias do Sistema Único de Saúde dos municípios do Maranhão para rastreamento do câncer do colo uterino. As amostras foram analisadas quanto à presença de anormalidades citológicas pelo método convencional e testadas para 37 genótipos de HPV por reação em cadeia da polimerase (PCR) com os iniciadores PGMY09/11, seguida de hibridização reversa em linhas através do Kit Linear Array HPV Genotyping Test (Roche Molecular System)®. A associação dos tipos de HPV e o diagnóstico citológico foi investigada de acordo com as diferentes faixas etárias. Resultados: A infecção pelo HPV foi detectada em 13% (46/353) das mulheres incluídas. Infecções por tipos de HPV de alto risco foram mais frequentes (78,3%; 36/46) do que por HPV de baixo risco (21,7%; 10/46). Os genótipos 68 (24,2% - 11/46); 58 (19,8% - 9/46); 52 e 31 (10,8% - 5/46 cada) e 62 (8,8% - 4/46) foram os mais prevalentes. Apenas 6,6% (3/46) dos casos foram positivos para o HPV 61. Os genótipos 73, 70, 54, 53, 45, IS39 e 18 representaram individualmente 4,4% (2/46) do total de casos. Os genótipos CP6-108, 84, 72, 71, 66, 59, 56, 55, 51, 39, 33, e 16 representaram individualmente 2,2% (1/46) do total de casos. Em mulheres que não apresentaram anormalidades citológicas, infecções virais, tanto simples quanto múltiplas, foram detectadas em 10,7%(35/328) dos casos. Considerando mulheres com diagnóstico de anormalidade citológica, a prevalência de infecção por HPV foi de 24,0% (11/46), sendo maior nos casos de lesão intraepitelial escamosa de alto grau (high grade squamous intaepithelial lesion)-HSIL-75,0%), seguida por mulheres com diagnóstico de células escamosas atípicas não podendo excluir alto grau (Atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions) ASC-H- 50%), com lesão intraepitelial escamosa de baixo grau (low grade squamous intraepithelial lesion) LSIL- 33,4%) e com diagnóstico de células escamosas atípicas de significado indeterminado (atypical squamous cells of undetermined significance ASC-US (14,3%). Houve uma associação estatisticamente significativa entre a infecção por HPV e a detecção de anormalidades citológicas nas faixas etárias de 31 a 40 anos (OR = 7,40; 95% CI:1,07–51,19, p=0,03) e 51 a 60 anos (OR=20,4, 95%CI: 1,12-704,69; p = 0,03). Nenhuma das variáveis comportamentais analisadas mostrou associação significante com a infecção por HPV, contudo a presença desta infecção foi positivamente associada à detecção de anormalidades citológicas (OR=6,57: IC:2,772-15.606), p=0,001. Conclusão: É possível que os resultados deste estudo se devam às características da população estudada: isolada geograficamente, com hábitos conservadores e relações sexuais apenas entre membros do quilombo. Este estudo em mulheres quilombolas permitiu delinear a epidemiologia desta infecção por HPV em populações residentes no Maranhão.
Souza, Jacqueline Mazzuchelli de. "Modelagem estrutural e análise In silico da proteína E6 do genêro Deltapapillomavirus." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/87/87131/tde-07062018-112148/.
Full textPapillomaviruses (PVs) are widely studied viruses, emphasizing their ability to infect the epithelial and mucosal tissues in several animals, including humans, causing benign lesions that may occasionally result in cancer. Among the genera that infect animals, Deltapapillomaviruses have a veterinary, ecological and historical importance because they are capable of infecting their natural host and other animals. Therefore, this work contemplates all viral types belonging to the Delta-PVs, including their history. Among the proteins translated by the PVs, three of them are considered oncogenic proteins: E5, E6 and E7. Determining the structure of a protein is crucial to the elucidation of its function, allowing applications in the areas of protein engineering, genomic annotation and rational design of drugs. The three-dimensional structure of the E6 protein of each viral type belonging to the genus Deltapapillomavirus was determined by molecular modeling by homology. The evolutionary history of these proteins was evaluated based on the generation of phylogenetic trees and their physicochemical properties were analyzed. In addition, due to its high degree of conservation, E6 has been shown to be useful as a molecular marker. Despite being considered rare, papillomas lesions were observed in sheep on a farm in the state of São Paulo. The molecular diagnosis of these lesions was performed. The results showed for the first time in the world that, despite being ovines, the causative agent of papillomatosis was a bovine papillomavirus, BPV2, a Delta-PV. Thus, in addition to discussing Delta-PVs, this thesis demonstrates in practice the ability of this genre to break the species-specific barrier.
RICHALET-SECORDEL, PASCALE. "Utilisation de peptides synthetiques dans le diagnostic immunochimique de maladies virales humaines : application au virus de l'immunodeficience humaine vih-1 et aux papillomavirus oncogenes." Université Louis Pasteur (Strasbourg) (1971-2008), 1994. http://www.theses.fr/1994STR13143.
Full textRosa, Maria Inês da. "O papilomavirus humano e lesões do colo uterino." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2007. http://hdl.handle.net/10183/12119.
Full textWe analysed a cohort of women in Southern Brazil with the aim to identify epidemiological correlates for persistence and clearance of cervical HPV infection. A quantitative systematic review was performed to estimate the accuracy of telomerase assay in cervical lesions. Methods: A cohort study was started on February 2003. Cervical smears were collected to perform Pap cytology and HPV DNA detection at baseline and during the follow up. The outcome was constructed in four categories (1) persistence of HPV DNA; (2) conversion; (3) clearance of HPV. Pearson’s χ2 test, multinomial logistic regression and univariate analysis using the log-rank test were performed. Meta-analysis studies that evaluated the telomerase test (telomerase repeated amplification protocol) for the diagnosis of cervix lesions and compared it to paraffin-embedded sections as the diagnostic standard were included. Results: Incidence of HPV DNA: 12.3%. HPV16 was the most frequent type (18.6%) among 501 women in the study. Thirty-four women were persistently infected with HPV, which was associated with age below 21 years at first intercourse (OR 3.14, 95% CI, 1.43-6.87) and ≥ 4 sexual partners during lifetime (OR 2.48, 95% CI, 1.14-5.41). In a median period of 19 months, 80.7% of women had clearance of HPV, which was associated with black race (OR 3.44, 95% CI, 1.55-7.65), co-infection with C. trachomatis at baseline (OR 3.26, 95% CI, 1.85-5.76) and history of previous Pap smear (OR 3.48, 95% CI, 1.51-8.00). In meta-analysis ten studies were analyzed, which included 1,069 women. The diagnostic odds ratio (DOR) for a positive telomerase test for Lo-SIL vs. normal or benign lesions was 3.2 (95% CI, 1.9-5.6). The DOR for a positive telomerase test for Hi-SIL vs. Lo-SIL, normal or benign lesions was 5.8 (95% CI, 3.1-10). For cervix cancer vs. Hi-SIL, the DOR for a positive telomerase test was 8.1 (95% CI, 3.2-20.3) and for cervix cancer vs. Lo-SIL, normal or benign lesions, it was 40.9 (95% CI, 18.2-91). Conclusions: Persistence of HPV infection wasassociated with early age at first intercourse and number of sexual partners during lifetime, suggesting that strategies for sexual orientation may modify the rates of HPV persistence. The association of HPV clearance with a history of previous Pap smear screening highlights the importance of improving cervical screening programs. Further studies on the association of gynaecological infections with HPV clearance are needed. In meta-analysis our data support the current hypothesis that telomerase may activate an early event in cervical carcinogenesis, that could be associated with the initiation and progression of cervical lesions.
Defayette, Danielle. "Surveys of Women with HPV and Their Healthcare Experiences." Digital Commons @ East Tennessee State University, 2013. https://dc.etsu.edu/honors/84.
Full textHanns, Elodie. "Analyse et caractérisation moléculaire de l'hypoxie intratumorale de carcinomes épidermoïdes de l'oropharynx." Thesis, Strasbourg, 2014. http://www.theses.fr/2014STRAJ063/document.
Full textHead and neck squamous cell carcinoma (HNSCC) represents the sixth most common malignancy worldwide. The major risk factors for HNSCC identified are tobacco use and alcohol consumption (80% of all HNSCC), which seem to have a synergistic effect. A subgroup of HNSCCs (20% of cases), particularly those of the oropharynx, is caused by infection with high-risk types of human papillomavirus (HPV). Human papillomavirus HPV-related oropharyngeal squamous cell carcinoma defines a distinct clinical subgroup of head and neck cancer patients with improved prognosis. Currently, one of the several hypothesis studied to account for their improved survival outcomes could be a distinct hypoxia status compared to their HPV-negative counterpart. Indeed, tumour hypoxia is common in solid tumours including head and neck tumours, and hypoxia is a well-known poor prognosis factor. In first part of this thesis, we have performed a molecular characterisation of tumor hypoxia on cohort of oropharyngeal tumours according to HPV status of the patients. The results support the hypothesis that HPV-related tumours display a lesser hypoxia status compared to HPV-negative oropharyngeal tumours. These HPV-related tumours also characterize by an abundant tumour vascularisation, which could be responsible for a lesser hypoxia status. In a second part, we have studied the ability of the adaptation to hypoxia of the HPV-positive SCC90 cell line and HPV-negative SQ20B cell line. Furthermore, HPV-positive and HPV-negative HNSCC xenograft models have been established and have been analysed about tumor hypoxia. Similar to HPV-related HNSCC, tumours-derived HPV positive cell lines display a reduced hypoxic status compared to tumours-derived HPV negative cell lines. The two cell lines adapt also differently to in vitro hypoxia. In the HPV-positive cell line, the hypoxia response pathways could be more dynamics. Indeed, SCC90 cell lines attempt to adapt and to reply to hypoxic environment inducing highly expression of all of the hypoxia related genes compared to SQ20B cell lines
Guillet, Julie. "Les papillomavirus Humains dans les cancers des Voies Aéro-Digestives Supérieures : optimisation de méthodes de détection et étude de populations à risque." Thesis, Université de Lorraine, 2016. http://www.theses.fr/2016LORR0050/document.
Full textThe Human Papillomavirus (HPV) are involved in almost 100% of cervical cancers. Recently, HPVs have been recognized as the cause of tumors of the upper aerodigestive tract, especially of squamous cell carcinoma of the oropharynx. In France, the proportion of oropharyngeal HPV-related tumors is unknown, partly because viral testing is not in guidelines. Moreover, assess the proportion of HPV-positive tumors in tumor banks is difficult because the tumor samples were fixed in formalin and embedded in paraffin (FFPE), which complicates detection techniques. We tested a high risk HPV detection method, indicated for liquid based pap smear, on FFPE samples. We compared this technique to the gold-standard : PCR (Polymerase Chain Reaction) followed by electrophoresis. Our results indicate that this technique is applicable to FFPE samples and even appears to be more sensitive. The majority of French patients (2/3) with head and neck consult with an advanced stage of disease. This is explained in part by the lack of organized screening of these cancers, contrary to breast, prostate, cervical, or colorectal cancers. But an early treatment is essential to increase the survival rate. We therefore conducted a prospective study on patients with head and neck tumors to test the oral brushing as screening cancer and HPV detection. We found tumor and/or dystrophic cells in 97.8% of patients with biopsy, and in 88.9% of patients by brushing. Compared with biopsy, our results suggested that smear has similar specificity for HPV detection in tumors (94.4%), but lower sensitivity (66.7%). This study has shown an HPV-related tumor in 12.2% of cases. Among them, we detected by brushing (in healthy area) an oral infection by high-risk HPV in 53.3% of cases. WHO has classified HPV as carcinogenic agents since 1995, and determined that patients who developed cervical cancer are six-times more likely to develop another HPV-related tumor. In this context, we have planned a multicenter prospective study to detect oral HPV infection in patients with a pre-neoplastic or neoplastic lesion of the cervix. Co-infection rate of the two anatomical sites is unknown in women infected with genital level. Insofar oral infection could be the cause of a second tumor location, it seems important to know how much women are co-infected to propose thereafter a special monitoring. The preventive vaccination, which exists against HPV 16 and 18 in the prevention of cervical cancer, is a future perspective. Because HPV 16 is found in 90% of HPV-related squamous cell carcinoma of the oropharynx, extending vaccine recommendations emerge as a new public health issue
RIBEIRO, Andrea Alves. "Prevalência de tipos específicos de Papilomavírus humano (HPV) e relação com a severidade da lesão cervical em mulheres com exame citopatológico anormal." Universidade Federal de Goiás, 2009. http://repositorio.bc.ufg.br/tede/handle/tde/1802.
Full textHuman papillomavirus (HPV) is considered the central etiological agent involved in the genesis of cervical cancer. The HPV viruses are classified according to their biological niche, oncogenic potential and phylogenetic position. According to the criteria established by the International Committee on Taxonomy of Viruses (ICTV), the various groups of human papillomaviruses that infect the female genital tract are classified phylogenetically in the Alphapapillomavirus genus, including species classified among phylogenetic species 1 and species 15. The main high risk HPV are classified in species 9 (HPV 16, 31, 33, 35, 52, 58, 67), and in species 7 (18, 39, 45, 59, 56, 66, 68 and 70). HPV 16 is the most prevalent type irrespective of diagnosis, principally in more severe lesions. Coinfection with multiple-types HPV is a common finding of many molecular studies. Some HPV types might interact or act synergistically to induce progression. Few studies have investigated the interactions of viral genotypes or species in multiple-type HPV infections. Therefore, the objective of this study was to evaluate the effect of single or multiple-types HPV infections considering also the phylogenetic groups on the prevalence and severity of cervical intraepithelial neoplasia (CIN) among women undergoing colposcopy following a abnormal cervical smear. Methodology: In this analysis, 198 women attending at the colposcopic clinic, because of an abnormal cervical smear were included. Colposcopy was carried out in all cases and biopsies were done in 193 of 198 women included. All specimens were tested for 27 HPV genotypes by Roche s polymerase chain reaction reverse line blot assay. Results: The overall prevalence of HPV in women with an abnormal cervical smear was 86% (171/198). Of the total of HPV-positive women, 45% (77/171) were infected with HPV 16 as a single or multiple-type infections. HPV 31 and 35 were, respectively, the second and third most prevalent types. The prevalence of HPV 16 in high grade cervical intraepithelial neoplasia (CIN2/3) was 52% (40/76) and it was detected in 88.8% (8/9) in cases of invasive carcinoma. The prevalence of type 31 and 35 in high grade CIN was respectively 10.5% (8/76) and 6.6% (5/76). Single HPV infection for any type was significantly associated with neoplastic diagnosis. High grade neoplastic diagnosis (≥ CIN2) was significantly associated with HPV 16 in single or multiple infections. Also, there was significantly association between HPV 16 and others types of specie 9 and high grade neoplastic diagnosis, but no association was observed considering the HPV 16 and other of groups of species 7 or others types. Conclusion: These results indicated that the type 16 is the most important predictor of high grade cervical neoplasia. Multiple-type infections are predictors of high grade cervical neoplasia when the type 16 is present.
O Papilomavírus humano (HPV) é considerado o agente etiológico central envolvido na gênese do câncer cervical. O vírus HPV é classificado de acordo com seu nicho biológico, potencial oncogênico e classificação filogenética. De acordo com os critérios estabelecidos pelo Comitê Internacional de Taxonomia dos Vírus (ICTV), os diversos tipos de HPV que infectam o trato genital feminino são classificados filogeneticamente no gênero Alphapapillomavirus. Esta classificação inclui espécies filogenéticas classificadas entre a espécie 1 e a espécie 15, dentre as quais, as de maior interesse em relação ao potencial carcinogênico são a espécie 9 (HPV 16, 31, 33, 35, 52, 58, 67) e a espécie 7 (18, 39, 45, 56, 59, 66, 68, 70). O HPV 16 é tipo o mais predominante, independente do diagnóstico, presente principalmente nas lesões cervicais mais graves. A co-infecção com múltiplos tipos de HPV é um achado comum em muitos estudos moleculares, contudo, as interações dos genótipos virais ou espécies envolvidas nas infecções por múltiplos tipos de HPV têm sido pouco analisadas. Portanto, o objetivo deste estudo foi avaliar o efeito das infecções simples ou por múltiplos tipos de HPV, considerando também os grupos filogenéticos, sobre a prevalência e a gravidade das neoplasias cervicais. Metodologia: Este estudo de corte transversal incluiu 198 mulheres encaminhadas ao Ambulatório de Colposcopia da Santa Casa de Misericórdia de Goiânia por exame citopatológico anormal. Todas as mulheres foram esclarecidas quanto aos objetivos de estudo e assinaram o termo de consentimento livre e esclarecido. A colposcopia foi realizada em todos os casos e a biópsia em 193 das 198 mulheres incluídas. As amostras foram testadas para 27 genótipos de HPV, por reação em cadeia da polimerase (PCR); em seguida foi realizada a hibridização reversa em pontos da Roche Diagnósticos. Resultados: A prevalência de HPV em mulheres encaminhadas por exame citopatológico anormal foi de 86% (171/198). Do total de mulheres HPV-positivas, 45% (77/171) estavam infectadas por HPV 16 em infecções simples e múltiplas. Os tipos de HPV 31 e 35 foram respectivamente, o segundo e o terceiro mais prevalentes. A prevalência do HPV 16 foi de 52% (40/76) nas neoplasias intra-epiteliais cervicais de alto grau (NIC 2/3) e de 88,8% (8/9) nos casos de carcinomas invasivos. As prevalências dos tipos 31 e 35 em neoplasias intra-epiteliais cervicais de alto grau (NIC 2/3) foram de 10,5% (8/76) e 6,6% (5/76), respectivamente. A infecção simples por qualquer tipo de HPV foi significativamente associada com diagnósticos neoplásicos de alto grau (≥ NIC 2). Os diagnósticos neoplásicos de alto grau (≥ NIC 2) foram significativamente associados com o HPV 16 em infecções simples ou múltiplas, mesmo depois de ajustado pela positividade para DNA de HPV. Houve significativa associação entre o HPV 16 e outros tipos da espécie 9 e os diagnósticos neoplásicos de alto grau (≥ NIC 2), mas não foi observada associação, considerando o HPV 16 e outros tipos da espécies 7 ou outros tipos de HPV. Conclusão: Estes resultados indicam que o HPV 16 parece ser o mais importante preditor de diagnósticos neoplásicos de alto grau. As infecções múltiplas são preditoras das neoplasias cervicais de alto grau quando o HPV 16 está presente.
Nahas, Caio Sergio Rizkallah. "Rastreamento da displasia anal em pacientes infectados pelo HIV: há concordância entre o estregaço anal e a biópsia guiada por anuscopia de alta resolução?" Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/5/5154/tde-10072012-145651/.
Full textPurpose: To analyze the agreement between anal Pap smear and high resolution anoscopy guided biopsy to diagnose anal dysplasia in HIV-infected patients. Methods: Cross sectional analysis of HIV-infected patients receiving anal dysplasia screening as part of routine care. Agreement between measures was estimated by weighted kappa-statistics, using 3-tiered cytologic and histologic grading system (normal, low grade dysplasia, and high grade dysplasia). Estimates of sensitivity, specificity, and predictive values were calculated using a 2-tiered cytologic and histologic grading system (without dysplasia, and with dysplasia of any grade). Estimates were also calculated for the detection of high grade dysplasia. Results: Two hundred and twenty-two patients underwent 330 anal Pap smears followed by high resolution anoscopy guided biopsies in one year period. There were 311 satisfactory Pap smears with concurrent biopsy. Considering histology the standard, the frequency of anal dysplasia was 46 percent (95 percent confidence interval: 40-51 percent). Kappa-agreement between anal Pap smear and biopsy was 0.20 (95 percent confidence interval: 0.10 0.29). Anal Pap smear showed sensitivity of 61 percent, specificity of 60 percent, positive predictive value of 56 percent, and negative predictive value of 64 percent for detection of anal dysplasia of any grade. For high grade dysplasia, anal Pap smear showed sensitivity of 16 percent, and specificity of 97 percent. Conclusion: The present study showed a low concordance between anal Pap smears and high resolution anoscopy-guided biopsy
Qadadri, Brahim. "Human papillomavirus type distribution in cervical cancer in Indiana and Botswana." Thesis, 2014. http://hdl.handle.net/1805/5223.
Full textIn this study we compared the distribution of HPV types in cervical cancer specimens from women living in either Indiana or Botswana. Paraffin-embedded blocks of formalin-fixed cervical cancer specimens were identified from women living in Indiana (n=51) or Botswana (n=171)
Edelman, Debra. "The psychosocial impact of being diagnosed with genital human papillomavirus." 1994. https://scholarworks.umass.edu/dissertations/AAI9434479.
Full textDelgado, Cândida Filipa Abreu de Castro. "Implementation and evaluation of new methodologies for early diagnosis of high risk Human Papillomavirus Infection." Master's thesis, 2009. http://hdl.handle.net/10451/1430.
Full textCervical cancer is the second most common cancer in women worldwide. Persistent infection by high-risk human papillomavirus (HR-HPV) is considered to play a central role in cervical carcinogenesis. The aim of this work was the implementation and evaluation of new methodologies for early diagnosis of HR-HPV infection. Cervical samples, with or without cytological abnormalities, were tested for HPV DNA by different methods. Four studies were developed, namely, the prevalence of HPV infection among a group of Portuguese women, the evaluation of a new diagnostic system for HR-HPV detection, the implementation and evaluation of real-time PCR methodologies, and a case-study in women infected with HPV 16 and 18. Statistical analyses were done using SPSS version 16.0. Prevalence data showed that genital HPV infection is common among Portuguese women, with an overall positivity of 43.5%. This infection is frequent especially in younger women (25-29 years). The 4 most prevalent HR-HPV were HPV 16 (25.3%), HPV 31 (11.3%), HPV 51 (10.3%), and HPV 66 (9.1%). Evaluation of the new Abbott RealTime HR HPV suggests that this system is efficient, sensitive, specific, robust, reproducible, and suitable for HPV screening, particularly for prediction of premalignant lesions (CIN2+). The real-time PCR methodologies analysed for assessing the viral load, the DNA integration, and the RNAm transcript expression were highly reproducible and accurate for HPV results obtained in the case-study. Results seem to indicate that these methodologies are important for patient management and for cervical cancer prevention in women infected with HPV 16 and 18. In conclusion, the results obtained in this study can help to understand HPV epidemiology prevalence in Portugal and to identify molecular markers that can be used as predictors of premalignant and malignant lesion development, contributing for a decrease in morbidity and mortality rates of women infected by HR-HPV.
Resumo alargado em português disponível no documento
Oliveira, Ana Catarina Gradíssimo de 1981. "New approaches for the diagnosis of human papillomavirus infection:relevance for clinical practice and cancer prevention." Doctoral thesis, 2014. http://hdl.handle.net/10451/10775.
Full textA relação entre a infecção pelo Vírus do Papiloma Humano (HPV) e o desenvolvimento do cancro do colo do útero foi estabelecida no final do século XX. Em Portugal, preconiza-se o rastreio do cancro do colo do útero na mulher adulta por constituir uma das neoplasias mais frequentes. Foram recentemente implementados programas de rastreio numa base regional; contudo, o respectivo impacto na redução do número de casos de cancro do colo do útero levará algum tempo. Por outro lado, o recurso a potenciais indicadores de prognóstico, permitirá auxiliar a identificação precoce de mulheres em risco de desenvolver cancro do colo do útero, contribuindo para o estabelecimento de estratégias de prevenção mais efectivas e eficazes. A vacina profiláctica contra a infecção por HPV foi recentemente disponibilizada para administração à população feminina jovem, tendo sido incluída no plano nacional de vacinação. Neste contexto, torna-se importante conhecer os genótipos circulantes na população Portuguesa, de forma a prever o impacto da vacinação (apenas inclui dois ou quatro genótipos de HPV) na infecção por HPV e nas lesões a esta associada. O presente trabalho de doutoramento teve os seguintes objectivos: 1) determinação da proporção da infecção pelos diferentes genótipos de HPV numa amostra da população feminina Portuguesa (obtida por rastreio oportunista), e respectiva associação com o diagnóstico citológico; 2) avaliação dos testes de detecção e genotipagem do HPV relativamente à clínica associada; 3) avaliação de diferentes indicadores de prognóstico, de acordo com o diagnóstico clínico; e, 4) desenvolvimento de um modelo matemático aplicável ao estudo da infecção genital por HPV. A determinação da frequência dos diferentes genótipos de HPV foi efectuada numa população com sinais clínicos sugestivos de infecção por HPV, tendo sido possível estabelecer associações significativas entre as alterações clínicas e a infecção persistente por genótipos de alto risco. Adicionalmente, foi possível identificar os genótipos mais frequentes, nomeadamente os HPV 16, 18, 31, 51, 53 e 66, e verificar que a infecção por HPV é mais frequente nas mulheres até aos 29 anos, sobretudo devido à multiplicidade de contactos e de parceiros sexuais (maioritariamente infecções transitórias). Já nas mulheres com idade superior a 30 anos, a infecção por HPV foi menos frequente mas apresentou maior risco de persistência e, dada a elevada proporção de genótipos de alto risco (mesmo em mulheres com citologia normal – assintomáticas), constituiu, por si só, um importante factor de risco para o desenvolvimento de cancro do colo do útero.Foi efectuada uma caracterização epidemiológica da infecção por HPV, assim como dos programas de rastreio do cancro do colo do útero em Portugal, tendo sido salientadas as especificidades do rastreio em cada região. O desempenho de diferentes testes comerciais de detecção e genotipagem do HPV foi avaliado de acordo com a clínica (sensibilidade, especificidade, valor preditivo positivo e negativo). A compreensão dos princípios e fundamentos de cada metodologia facilita uma correcta apreciação do respectivo desempenho laboratorial em fases distintas da infecção por HPV, assim como da sua aplicabilidade a programas de rastreio. Os testes de detecção do DNA viral, com elevada sensibilidade, revelaram constituir uma boa alternativa à recorrente citologia, enquanto teste de rastreio primário. De facto, a abordagem conjunta de teste HPV com triagem citológica, especialmente nas mulheres com mais de 30 anos, permitirá alargar o tempo de intervalo entre os exames de rastreio, devido ao elevado valor preditivo negativo do teste HPV. Mais, os testes de detecção do DNA viral, que incluem a genotipagem dos HPV 16 e 18 (oncogénicos e frequentemente associados ao desenvolvimento de lesões precursoras de cancro do colo do útero), possibilitam estratificar mais eficazmente as mulheres em maior risco de persistência da infecção viral e respectivas consequências clínicas. Relativamente à detecção de RNAm do HPV, foi avaliada uma metodologia comercial de detecção e genotipagem de transcritos de RNAm para alguns genótipos de HPV de alto risco (NASBA). Esta metodologia permite a identificação precoce de infecções clinicamente relevantes por compreenderem um risco acrescido de desenvolvimento de lesões precursoras do cancro do colo do útero. Verificou-se que a utilização desta metodologia como teste de segunda linha pode aumentar a especificidade do teste de detecção de DNA do HPV nas mulheres infectadas, reduzindo a indicação clínica para colposcopia (que inflige elevada morbilidade e ansiedade na mulher) como método de rastreio das lesões associadas à infecção por HPV, e evitando o tratamento excessivo, ao possibilitar excluir lesões com maior probabilidade de regressão. A utilização de diferentes indicadores de prognóstico da infecção por HPV facilitará a identificação precoce de mulheres em risco de desenvolvimento de lesões precursoras de cancro do colo do útero. Neste contexto, foram avaliadas a carga viral e o estado físico do DNA viral dos HPVs 16 e 18, tendo sido possível determinar uma associação entre o aumento da carga viral do HPV 16 e a gravidade da lesão do colo do útero, pelo que foi considerado como um importante marcador de prognóstico em mulheres infectadas por um dos mais frequentes genótipos de alto risco na população Portuguesa. Para o HPV 18, frequentemente associado ao desenvolvimento de adenocarcinomas (tipo de cancro cervical de difícil identificação citológica), verificou-se que a carga viral é potencialmente preditiva da persistência da infecção.A determinação do estado físico do DNA viral, como metodologia alternativa a procedimentos médicos invasivos (colposcopia e biopsia), foi avaliada em associação com o diagnóstico citopatológico. Durante o processo de carcinogénese viral ocorre integração do genoma viral no genoma da célula hospedeira, por disrupção do gene viral E2 e subsequente sobre -expressão dos oncogenes virais E6 e E7. Foi possível identificar, especialmente para o HPV 18, uma associação entre a presença de formas lineares (maior risco), as lesões precursoras e os casos de adenocarcinoma, o que sugere a utilidade clínica deste indicador de prognóstico para as mulheres infectadas por HPV 18. No caso do HPV 16, a associação entre a determinação do estado físico do DNA viral e o diagnóstico citopatológico não foi tão evidente, pelo que outros mecanismos virais poderão estar associados à transformação maligna que antecede o desenvolvimento de cancro do colo do útero. Por último, o desenvolvimento de um modelo matemático aplicado à infecção genital por HPV incluiu transições entre os diferentes estadios clínicos que correspondem ao processo de carcinogénese viral. Os cenários previstos foram extrapolados a partir da população de estudo (de rastreio oportunista) e posteriormente comparados com uma população Portuguesa de referência (de rastreio organizado), por forma a estimar a evolução e flutuações relacionadas com a infecção por genótipos de HPV de alto risco e respectivas lesões associadas. A utilização eficaz da vacina a nível mundial poderá levar a uma diminuição de casos de cancro do colo do útero na ordem dos 70% (valor estimado de cancros associados à infecção por HPV 16 e 18), decorrente da prevenção vacinal para os referidos HPVs. No entanto, a existência de uma proporção considerável de outros genótipos de alto risco não incluídos nas vacinas disponíveis poderá alterar esta estimativa, pelo que a monitorização constante dos genótipos circulantes de HPV será importante. De facto, estima-se que sejam necessárias algumas décadas até eliminar os casos de infecção associados aos HPV 16 e 18, já que a grande maioria das mulheres já foi exposta à infecção por HPV.
Cervical cancer development has been aetiologically linked to human papillomavirus (HPV) infection. In Portugal, routine screening for cervical cancer has been regionally implemented and was recommended for adult women because it constitutes one of the most frequent malignancies for women aged 15 to 44 years. HPV prophylactic vaccination (which only includes two or four oncogenic genotypes) was made available in the last decade for young girls, but the knowledge of HPV circulating genotypes is crucial for predicting its clinical impact. This PhD thesis comprised the following objectives: 1) assessment of the proportion of HPV genotypes among Portuguese women (opportunistic screening) according to cytological diagnosis; 2) clinical evaluation of several HPV tests; 3) evaluation of some prognostic markers according to the clinical diagnosis; 4) development of a mathematical model applied to genital HPV infection. Portuguese HPV epidemiology and screening programs were characterized, highlighting the specificities of screening in each region. The most frequent genotypes were HPV 16, 18, 31, 51, 53 and 66, and HPV infection was more common in women aged less than 29 years. In women over 30 years, HPV infection was less frequent but tend to persist and to involve high-risk genotypes. HPV DNA tests demonstrated high sensitivity, constituting an alternative to cytology in primary screening, while combined with cytology (especially for women over 30 years) would extend the re-screening testing interval, considering the high negative predictive value of HPV testing. Moreover, HPV DNA tests with concurrent identification of HPV 16 and 18 (most associated genotypes to cervical cancer development) will provide a better risk stratification of women for precancerous cervical lesion development. The detection of HPV mRNA is highly specific in identifying clinical cervical disease, so that its recommendation to reflex testing of HPV DNA-positive women has shown to reduce colposcopy referral, avoiding over-treatment by excluding cervical lesions that would most likely regress (with associated morbidity and anxiety to HPV-infected women). The viral load and physical status of high-risk HPV 16 and 18 were evaluated as prognostic markers in women at risk of developing cervical precancerous lesions. An association between increased HPV 16 viral load and severity of cervical lesion was observed suggesting its prognostic value, whereas for HPV 18, viral load was only predictive of HPV persistency. The presence of linear forms (higher risk) in HPV 18-associated precancerous lesions and adenocarcinomas evidenced the potential clinical utility of viral DNA physical status as a prognostic marker for women infected with HPV 18. The association was not evident for HPV 16, suggesting that other viral mechanisms should be responsible for malignant host cell transformation.Finally, the mathematical model applied to genital HPV infection included transition probabilities between disease states corresponding to different steps of cervical carcinogenesis, and provided scenarios for a Study Population (opportunistic screening), for a Reference Population (routine screening) and for a Hypothetical Population, which were further compared to predict HPV vaccination impact. Estimates of trends and fluctuations associated with high-risk HPV genotype infections and its associated cervical lesions were performed. HPV vaccines may lead to a global decrease of cervical cancer cases of about 70%, considering that most cervical cancers are associated with HPV 16 and 18 infections. However, the existence of a considerable proportion of other highrisk genotypes not included in the currently available HPV vaccines may change this estimate. Thus, the constant monitoring of circulating HPV genotypes remains of particular importance. Furthermore, the vast majority of women have been exposed to HPV infection, alerting to the importance of a continuous follow-up and establishment of public health measures through routine screening, while improving women’s welfare.
Fundação para a Ciência e a Tecnologia (FCT, SFRH/BD/47044/2008)
Wong, Winnie S. "A multiplexed human papillomavirus (HPV) 16 and 18 diagnostic for cervical cancer screening." Thesis, 2019. https://hdl.handle.net/2144/34408.
Full textDavis, Aisha. "Real time PCR and fluorescent in situ hybridization in the detection of the physical tsate of human papillomavirus 16 and 18 in paraffin embedded cervical tissue." 2015. http://hdl.handle.net/1805/7968.
Full textHuman papillomaviruses (HPV) are the etiologic agents of most cervical dysplasia and all cervical carcinoma. Integration of high risk HPV into the human genome is thought to be a critical event in the progression from cervical dysplasia to invasive cervical carcinoma. The ability to use molecular assays in the detection and evaluation of HPV integration is essential in informing clinical models for early intervention and therapies. We therefore sought to determine the feasibility of real time-PCR (RT-PCR) as a molecular tool in detecting the physical state, episomal versus integration of HPV 16 and 18 DNA in cervical cancers. Tyramide amplified fluorescent DNA in situ hybridization (FISH) was used to look for evidence of HPV 16/18 integration using formalin-fixed, paraffin-embedded sections of cervical carcinomas. RT-PCR used the ratio of the E2 and E6 genes as a surrogate for determining the physical state of HPV 16 and 18 in 35 infected tissues. Results of RT-PCR showed that 16 cervical specimens (45.7%) contained episomal HPV, 17 cervical samples (48.6%) harbored the integrated form of HPV DNA, and 2 samples (5.7 %) contained both integrated and episomal forms of HPV. Results of the two assays were compared in 25 cervical carcinomas. For 13 of the 25 cervical samples there was an agreement in determining the physical state of HPV. RT-PCR, using the E2/E6 ratio as an assay for HPV integration appears to be promising and may prove to be an essential clinical method in the future.
"Expression and Purification of HPV Proteins for Early Detection of Head and Neck Cancer." Master's thesis, 2019. http://hdl.handle.net/2286/R.I.54997.
Full textDissertation/Thesis
Masters Thesis Molecular and Cellular Biology 2019
"Modeling, Design, Fabrication, and Characterization of a Highly Sensitive Fluorescence-based Detection Platform for Point-of-Care Applications." Doctoral diss., 2018. http://hdl.handle.net/2286/R.I.51705.
Full textDissertation/Thesis
Doctoral Dissertation Electrical Engineering 2018